Product Information

POTASSIUM CL ER 20 MEQ TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.1695 per EA under NDC 72888007601. Its NADAC has been published 181 times since Mar 8, 2023.

FDA first approved this application on Jul 25, 2022. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CL ER 20 MEQ TABLET

Potassium Chloride
$0.1695per EA

Strength

1500 mg/1

NDC

72888007601

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA215725

FDA Approved

7/25/2022

TE Code

AB3

On Market Since

7/25/2022

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for POTASSIUM CL ER 20 MEQ TABLET has been published 181 times since Mar 8, 2023, and over the history we have for it it has declined 40.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1695 per EA
All-time high$0.3125 (Apr 10, 2024)
All-time low$0.1290 (Nov 20, 2024)
52-week high$0.1773
52-week low$0.1593
Median price$0.1773
Average price$0.2107
Largest weekly change+66.3% (Aug 21, 2024)
Weeks tracked181
Tracking sinceMar 8, 2023

Price History

1W

+6.4%

1M

+6.4%

3M

+3.7%

6M

+5.3%

1Y

-4.4%

3Y

-36.0%

5Y

N/A

All

-40.2%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of POTASSIUM CL ER 20 MEQ TABLET?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 20 MEQ TABLET, manufactured by Advagen Pharma Ltd., is $0.1695 per EA (NDC 72888007601), effective Aug 19, 2026.

How has the price of POTASSIUM CL ER 20 MEQ TABLET changed over time?

Over the history we have for it, the NADAC for POTASSIUM CL ER 20 MEQ TABLET has declined 40.2%. It has been tracked across 181 weekly CMS publications since Mar 8, 2023.

What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 20 MEQ TABLET?

Since Mar 8, 2023, the NADAC for POTASSIUM CL ER 20 MEQ TABLET has ranged from a low of $0.1290 (Nov 20, 2024) to a high of $0.3125 (Apr 10, 2024), with a median of $0.1773 per EA.

Are there cheaper alternatives to POTASSIUM CL ER 20 MEQ TABLET?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CL ER 20 MEQ TABLET, is $0.1351 per EA — about 20% below POTASSIUM CL ER 20 MEQ TABLET.

Who manufactures POTASSIUM CL ER 20 MEQ TABLET?

POTASSIUM CL ER 20 MEQ TABLET (NDC 72888007601) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.